Dr. Allan Lipton, MD

NPI: 1114976891
Total Payments
$3,539
2020 Payments
$2,000
Companies
5
Transactions
9

Payment Breakdown by Category

Other$2,500 (70.6%)
Consulting$900.00 (25.4%)
Food & Beverage$139.49 (3.9%)

Payments by Nature

Nature of Payment Amount Transactions Share
Honoraria $2,500 4 70.6%
Consulting Fee $900.00 1 25.4%
Food and Beverage $139.49 4 3.9%

Top Paying Companies

Company Total Records Latest Year
Athenex Pharmaceutical Division, LLC $2,500 4 $0 (2020)
Halozyme Inc $900.00 1 $0 (2019)
Novartis Pharmaceuticals Corporation $74.89 2 $0 (2018)
AstraZeneca Pharmaceuticals LP $38.29 1 $0 (2017)
Merck Sharp & Dohme Corporation $26.31 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2020 $2,000 3 Athenex Pharmaceutical Division, LLC ($2,000)
2019 $1,400 2 Halozyme Inc ($900.00)
2018 $38.29 1 Novartis Pharmaceuticals Corporation ($38.29)
2017 $101.20 3 AstraZeneca Pharmaceuticals LP ($38.29)

All Payment Transactions

9 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
10/29/2020 Athenex Pharmaceutical Division, LLC Oral Paclitaxel (Drug), Encequidar Honoraria Cash or cash equivalent $750.00 General
Category: Metastatic Breast Cancer
06/18/2020 Athenex Pharmaceutical Division, LLC Oral Paclitaxel (Drug), Encequidar Honoraria Cash or cash equivalent $750.00 General
Category: Metastatic Breast Cancer
02/03/2020 Athenex Pharmaceutical Division, LLC Oral Paclitaxel (Drug), Encequidar Honoraria Cash or cash equivalent $500.00 General
Category: Metastatic Breast Cancer
07/11/2019 Athenex Pharmaceutical Division, LLC Oral Paclitaxel (Drug), Encequidar Honoraria Cash or cash equivalent $500.00 General
Category: Metastatic Breast Cancer
03/20/2019 Halozyme Inc Hylenex (Drug) Consulting Fee Cash or cash equivalent $900.00 General
Category: Opthalmology
12/05/2018 Novartis Pharmaceuticals Corporation PIQRAY (Drug) Food and Beverage In-kind items and services $38.29 General
Category: ONCOLOGY
12/08/2017 Novartis Pharmaceuticals Corporation KISQALI (Drug) Food and Beverage In-kind items and services $36.60 General
Category: ONCOLOGY
12/08/2017 Merck Sharp & Dohme Corporation Food and Beverage In-kind items and services $26.31 General
12/07/2017 AstraZeneca Pharmaceuticals LP LYNPARZA (Drug) Food and Beverage In-kind items and services $38.29 General
Category: Oncology

About Dr. Allan Lipton, MD

Dr. Allan Lipton, MD is a Medical Oncology healthcare provider based in Hershey, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114976891.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Allan Lipton, MD has received a total of $3,539 in payments from pharmaceutical and medical device companies, with $2,000 received in 2020. These payments were reported across 9 transactions from 5 companies. The most common payment nature is "Honoraria" ($2,500).

Practice Information

  • Specialty Medical Oncology
  • Location Hershey, PA
  • Active Since 05/09/2006
  • Last Updated 11/10/2009
  • Taxonomy Code 207RX0202X
  • Entity Type Individual
  • NPI Number 1114976891

Products in Payments

  • Oral Paclitaxel (Drug) $2,500
  • Hylenex (Drug) $900.00
  • LYNPARZA (Drug) $38.29
  • PIQRAY (Drug) $38.29
  • KISQALI (Drug) $36.60

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Medical Oncology Doctors in Hershey